• PixarBio Ups The Ante For InVivo, Strings Attached

    PixarBio offered $100 million in stock for InVivo Therapeutics Corp., but only if certain directors to get the boot.Amanda Pedersen Frank Reynolds upped the ante in PixarBio Corp.’s hostile takeover bid for his former company, InViVo Therapeutics Corp., but there are strings attached.Don't miss the MD&M West conference and expo, February 7-9, 2017, in Anaheim, CA.PixarBio is now offering $100 million in stock to acquire Cambridge, MA-based InVivo, but only if board members Richard...
  • Johnson & Johnson’s Latest 3-D Printing Collaboration

    DePuy Synthes is collaborating with Aspect Biosystems on a 3-D printed artificial meniscus.Marie ThibaultJohnson & Johnson is adding another 3-D printing partnership to its resume.Johnson & Johnson Innovation LLC has announced that DePuy Synthes Products is collaborating with Aspect Biosystems on knee meniscus tissue to be created using Aspect’s Lab-on-a-Printer bioprinting technology. The innovation is aiming to improve patient results after treatment for a torn meniscus. The...
  • Is Reynolds Playing The Trump Card To Get InVivo Back?

    PixarBio CEO’s hostile takeover bid for InVivo Therapeutics, the company he abruptly quit three years ago, has current management shaking their heads. Amanda Pedersen Frank Reynolds wants to take over the company he abruptly quit three years ago, and he’s playing the Trump card to make it happen.In launching a hostile takeover bid for his former company, InVivo Therapeutics Holdings Corp., Reynolds not-so-subtly tied himself to President-Elect Donald Trump as a “fellow Wharton alumni...
  • Cleveland Clinic Team 'Navigates' Tricuspid Regurgitation Case

    Doctors implanted a new valved stent from Navigate Cardiac Structures Inc. into a patient with severe tricuspid regurgitation under a compassionate plea.Amanda PedersenLong and short axis TEE views of the Gate atrioventricular valved stent implanted in the tricuspid valve of a beating heart of swine  A 64-year-old woman with an extensive history of severe tricuspid regurgitation received a new valved stent for the condition through a compassionate plea.Don't miss the MD&...
  • Call for Entries: MD&M West 2017 Innovation Prize

    UBM is looking to identify the most innovative exhibitors at MD&M West and give them the recognition they deserve. The MD&M West Innovation Prize is a contest acknowledging the most innovative products, services, and technologies developed in recent years by exhibitors at the conference and expo, held February 7–9, 2017, in Anaheim, CA.Finalists in the contest will be honored at the show as well as on UBM’s industry-leading Qmed media brand. Finalists will also...
  • MD&M West 2017 Innovation Prize Official Rules

    NO PURCHASE OR PAYMENT OF ANY KIND IS NECESSARY TO ENTER OR WIN. A PURCHASE OR PAYMENT WILL NOT IMPROVE YOUR CHANCES OF WINNING. CONTEST IS VALID ONLY IN THE UNITED STATES (EXCLUDING PUERTO RICO) AND CANADA (EXCLUDING QUEBEC) – ENTRIES FROM PERSONS LIVING IN OTHER COUNTRIES WILL BE AUTOMATICALLY DISQUALIFIED. GENERAL CONDITIONS:The MD&M West Innovation Prize (the “Contest”) is sponsored by UBM LLC, 2901 28th St., Ste. 100, Santa Monica, CA 90405 (“UBM” or “...
  • Let The Countdown Begin: Abbott-St. Jude Deal Draws To A Close

    With regulatory hurdles cleared, Abbott is expected to finalize its $25 billion acquisition of St. Jude Medical this week.Amanda PedersenAbbott's headquarters in Abbott Park, IL The countdown is officially on for Abbott Laboratories and St. Jude Medical Inc. Abbott said it has secured all necessary regulatory clearances and plans to close the deal Wednesday.Don't miss the MD&M West conference and expo, February 7-9, 2017, in Anaheim, CA.Miles White, chairman and CEO of the Abbott Park...
  • How To Nip Problems In The Bud The Endologix Way

     Endologix’s approach of stepping out in front of its manufacturing problem stands in stark contrast to that of Olympus, which swept a major safety concern under the rug.Amanda Pedersen All manufacturers run into snafus from time to time, but what sets one apart from another is how the management team reacts to the situation.Two recent Qmed stories, posted just a week apart, show a stark contrast between an organization that appears to have swept a major safety concern under the rug,...
  • Appeals Court Decision a Step Back for Medtronic

    The Eighth Circuit Court of Appeals has vacated a district court summary judgment granted to Medtronic in 2015, putting a securities fraud class action suit related to the company's INFUSE product back on the table.Marie ThibaultAn appeals court has vacated a district court summary judgment for Medtronic in a securities fraud class action suit involving the company’s INFUSE product.In a December 28 judgment, the Eighth Circuit Court of Appeals in St. Louis vacated a September 2015 summary...
  • Three Ways Exact Sciences Is Winning Insurers Over

    Stool test maker attributes insurance coverage success to value proposition.Amanda PedersenHumana recently joined a growing list of commercial insurers that now cover the Cologuard stool-based cancer test from Exact Sciences Corp. There may not be an exact science to getting payers to cover new technology, but having a strong value proposition seems to be a good place to start.Don't miss the MD&M West conference and expo, February 7-9, 2017, in Anaheim, CA.Here’s how Exact...
  • This Is How Varian Spinoff Could Get Big Fast

    Varian’s imaging spinoff isn’t even final and the new company is already making deals.Amanda PedersenVarex Imaging is kicking off its growth strategy early Varian Medical Systems Inc.’s medical imaging spinoff is putting its cart before its horse – for good reason.Don't Miss The MD&M West 2017 conference and expo, February 7-9, 2017, in Anaheim, CA.While its split from Varian won’t be final until January, Varex Imaging Corp. has already agreed to snap up PerkinElmer’s medical imaging...
  • The Healthcare Cyber Threats to Worry About in 2017

    A report points out that hijacking of medical devices and broader use of ransomware both increased in 2016, and warns of the new healthcare cyber risks coming in 2017.Marie ThibaultLooking back on cybersecurity in healthcare in 2016, researchers determined that both the practice of medical device hijacks and the wide use of ransomware became more commonplace this year.Frightening as that trend may be, security experts from TrapX Labs, a division of TrapX Security, Inc., predict more...
  • Did Endologix Bite Off More Than It Could Chew?

    Endologix seems to be taking a proactive stance to nip an AFX manufacturing glitch in the bud, but analysts wonder if the company’s portfolio is just too broad. The company expects to share more details by the end of the week.Amanda PedersenEndologix Inc. put shipments of its AFX system on hold Tuesday after finding damage to the graft material in certain larger sizes of the product that is more difficult to make. Endologix Inc. management spent the holiday weekend investigating...
  • Blood Test Predicts Cancer Survival Time

    New models based on test results may help doctors and patients decide whether and when to discontinue aggressive treatment.Nancy CrottiA routine blood test can predict how long cancer patients in palliative care will survive, researchers reported at an oncology conference in Singapore this week.Researchers at Kyoto University Hospital in Japan developed six adaptable prognostic (SAP) models that use laboratory measurements for albumin, neutrophil, and lactate dehydrogenase, which are routinely...
  • How To Teach Old Dogs New Tricks With ctDNA

    Clinical Genomics’ new blood test does the same thing as a 1970s test, only better.Amanda Pedersen If old dogs can indeed be taught new tricks, perhaps the same is true for blood tests. That appears to be the case with a new blood-based test for colorectal cancer (CRC) recurrence monitoring developed by Clinical Genomics.Don't miss the MD&M West conference and expo, February 7-9, 2017, in Anaheim, CA.While the test does fall under the rather broad, and arguably vague, umbrella of...
  • This Is Why China Should Zip It

    Zipline Medical has Chinese Market Approval all zipped up.Amanda PedersenZipline Medical's Zip surgical skin closure device is now approved in China. A Silicon Valley company has a shot at zipping up the $543 million Chinese wound closure market. Campbell, CA-based Zipline Medical Inc. secured approval from the China Food and Drug Administration (CFDA) to sell its Zip surgical skin closure device in the region.Don't miss the MD&M West 2017 conference and expo, February 7-9, 2017,...
  • Don't Stop Believin' In A Fingerstick-Free Future

    FDA approval of Dexcom’s dosing claim is seen as a major stride in the journey to eliminate finger pricks for good in diabetes management.Amanda PedersenDexcom's G5 is the first FDA-approved continuous glucose monitoring device to win dosing claim, allowing patients to rely on the CGM readings for daily treatment decisions, with fewer fingerpricks A new FDA label approval this week represented a big step for Dexcom Inc., and an even bigger step for the diabetes management...
  • Could This Bionic Pancreas Be the Best Solution?

    New data published from a small clinical trial with the bionic pancreas from Beta Bionics shows therapy with the device offers good control over blood glucose levels with little patient input required.Marie ThibaultThough diabetes device technology has improved markedly in recent years, patients still shoulder the heavy day-to-day burden of managing the disease.Still, there is plenty of reason to be optimistic about the future of diabetes device innovation, especially when considering data...
  • Johnson & Johnson to Open Health Tech Center

    Healthcare giant Johnson & Johnson plans to open a health technology center in Rhode Island, with employees focused on information technology and software apps.Marie ThibaultJohnson & Johnson has announced it will open a new health technology center in Providence, Rhode Island. The announcement is evidence of the bellwether's investment in value-based care, since the center’s employees will develop software applications and information technology solutions focused on health outcomes.The...
  • Light 'Em Up: Cancer 'Light Switch' Shows Surgeons Where To Cut

    Amanda PedersenThe nanosensors lit up on this image show cancer tissue at the microscopic level. The blue background is muscle tissue.Scientists have figured out how to switch cancer tissue on "like a light bulb" so that surgeons can see tumors better.The UT Southwestern Medical Center researchers invented a transistor-like threshold nanosensor to illuminate cancer tissue and tested it out in mice. The study is published Nature Biomedical Engineering.Don't miss the MD&M West...